These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16030191)

  • 1. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.
    Prandoni P; Siragusa S; Girolami B; Fabris F;
    Blood; 2005 Nov; 106(9):3049-54. PubMed ID: 16030191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.
    Girolami B; Prandoni P; Stefani PM; Tanduo C; Sabbion P; Eichler P; Ramon R; Baggio G; Fabris F; Girolami A
    Blood; 2003 Apr; 101(8):2955-9. PubMed ID: 12480713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation].
    Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H
    Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-associated thrombocytopenia in 24,401 patients with venous thromboembolism: findings from the RIETE Registry.
    Falvo N; Bonithon-Kopp C; Rivron Guillot K; Todoli JA; Jiménez-Gil M; Di Micco P; Monreal M;
    J Thromb Haemost; 2011 Sep; 9(9):1761-8. PubMed ID: 21676169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin.
    Lindhoff-Last E; Nakov R; Misselwitz F; Breddin HK; Bauersachs R
    Br J Haematol; 2002 Sep; 118(4):1137-42. PubMed ID: 12199798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
    Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review.
    Bloemen A; Testroote MJ; Janssen-Heijnen ML; Janzing HM
    Injury; 2012 May; 43(5):548-52. PubMed ID: 21640991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Warkentin TE; Greinacher A
    Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.
    Martel N; Lee J; Wells PS
    Blood; 2005 Oct; 106(8):2710-5. PubMed ID: 15985543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia.
    Gruel Y; Pouplard C; Nguyen P; Borg JY; Derlon A; Juhan-Vague I; Regnault V; Samama M;
    Br J Haematol; 2003 Jun; 121(5):786-92. PubMed ID: 12780795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the patient population on the risk for heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JA; Horsewood P; Simpson PJ; Moore JC; Kelton JG
    Blood; 2000 Sep; 96(5):1703-8. PubMed ID: 10961867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
    Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
    Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
    Bucci C; Geerts WH; Sinclair A; Fremes SE
    Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
    J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
    Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y
    Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.
    Lubenow N; Hinz P; Thomaschewski S; Lietz T; Vogler M; Ladwig A; Jünger M; Nauck M; Schellong S; Wander K; Engel G; Ekkernkamp A; Greinacher A
    Blood; 2010 Mar; 115(9):1797-803. PubMed ID: 19965682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.